Angiotensin II and endothelin-1 regulate MAP kinases through different redox-dependent mechanisms in human vascular smooth muscle cells

Objective The role of reactive oxygen species (ROS) in mitogen-activated protein kinase (MAPK) signaling by angiotensin (Ang) II and endothelin-1 (ET-1) in human vascular smooth muscle cells (VSMC) was investigated. Design VSMCs were derived from resistance arteries from healthy subjects. MAPK activity was assessed using phospho-specific antibodies. ROS generation was measured by CMH2DCFDA fluorescence and nicotinamide adenine dinucleotide phosphate (NADPH) oxidase activity by lucigenin chemiluminescence. Results Ang II and ET-1 increased MAPK phosphorylation (P < 0.01). Pre-treatment with Tiron and Tempol, •O2− scavengers, attenuated agonist-stimulated phosphorylation of p38MAPK, c-Jun N-terminal kinases (JNK) and ERK5, but not of ERK1/2 (extracellular signal-regulated kinases). Apocynin and diphenylene iodinium (DPI), NAD(P)H oxidase inhibitors, decreased Ang II-induced responses 60–70%. ET-1-mediated MAPK phosphorylation was unaffected by apocynin but was reduced (> 50%) by thenoyltrifluoroacetone (TIFT) and carboxyl cyanide-m-chlorophenylhydrazone (CCCP), mitochondrial inhibitors. Allopurinol and Nω-nitro-l-arginine methyl ester (l-NAME), xanthine oxidase and nitric oxide synthase (NOS) inhibitors, respectively, did not influence MAPK activation. Intracellular ROS generation, was increased by Ang II and ET-1 (P < 0.01). DPI inhibited Ang II- but not ET-1-mediated ROS production. Expression of p22phox and p47phox and activation of NAD(P)H oxidase were increased by Ang II but not by ET-1. CCCP and TIFT significantly attenuated ET-1-mediated ROS formation (P < 0.05), without influencing Ang II effects. Conclusions Ang II activates p38MAPK, JNK and ERK5 primarily through NAD(P)H oxidase-generated ROS. ET-1 stimulates these kinases via redox-sensitive processes that involve mitochondrial-derived ROS. These data suggest that redox-dependent activation of MAPKs by Ang II and ET-1 occur through distinct ROS-generating systems that could contribute to differential signaling by these agonists in VSMCs.

[1]  M. Fujita,et al.  Effects of endothelin-1 on mitochondrial function during the protection against myocardial cell apoptosis. , 2003, Biochemical and biophysical research communications.

[2]  N. Weissmann,et al.  Essential role of complex II of the respiratory chain in hypoxia-induced ROS generation in the pulmonary vasculature. , 2003, American journal of physiology. Lung cellular and molecular physiology.

[3]  T. Cheng,et al.  Crucial role of extracellular signal-regulated kinase pathway in reactive oxygen species-mediated endothelin-1 gene expression induced by endothelin-1 in rat cardiac fibroblasts. , 2003, Molecular pharmacology.

[4]  Stephanie W. Watts,et al.  Endothelin-1 Increases Vascular Superoxide via EndothelinA–NADPH Oxidase Pathway in Low-Renin Hypertension , 2003, Circulation.

[5]  E. Schiffrin,et al.  Redox-dependent MAP kinase signaling by Ang II in vascular smooth muscle cells: role of receptor tyrosine kinase transactivation. , 2003, Canadian journal of physiology and pharmacology.

[6]  M. Yoshizumi,et al.  Antioxidants inhibit endothelin-1 (1-31)-induced proliferation of vascular smooth muscle cells via the inhibition of mitogen-activated protein (MAP) kinase and activator protein-1 (AP-1). , 2002, Biochemical pharmacology.

[7]  E. Schiffrin,et al.  Expression of a Functionally Active gp91phox-Containing Neutrophil-Type NAD(P)H Oxidase in Smooth Muscle Cells From Human Resistance Arteries: Regulation by Angiotensin II , 2002, Circulation research.

[8]  A. Ishihata,et al.  Involvement of p44/42 mitogen-activated protein kinases in regulating angiotensin II- and endothelin-1-induced contraction of rat thoracic aorta. , 2002, European journal of pharmacology.

[9]  M. Yoshizumi,et al.  Hydrogen Peroxide Stimulates c-Src-mediated Big Mitogen-activated Protein Kinase 1 (BMK1) and the MEF2C Signaling Pathway in PC12 Cells , 2002, The Journal of Biological Chemistry.

[10]  C. Lowenstein,et al.  Hydrogen peroxide regulation of bovine endothelin-converting enzyme-1. , 2002, Free radical biology & medicine.

[11]  C. Kim,et al.  Vascular NADH oxidase is involved in impaired endothelium-dependent vasodilation in OLETF rats, a model of type 2 diabetes. , 2002, Diabetes.

[12]  Y. Kakinuma,et al.  Endothelin-1 Production Is Enhanced by Rotenone, a Mitochondrial Complex I Inhibitor, in Cultured Rat Cardiomyocytes , 2001, Journal of cardiovascular pharmacology.

[13]  H. Schmidt,et al.  Upregulation of the vascular NAD(P)H-oxidase isoforms Nox1 and Nox4 by the renin-angiotensin system in vitro and in vivo. , 2001, Free radical biology & medicine.

[14]  T. Suzuki,et al.  Endothelin-1 stimulates cardiomyocyte injury during mitochondrial dysfunction in culture. , 2001, European journal of pharmacology.

[15]  E. Schiffrin,et al.  A Critical Review of the Role of Endothelial Factors in the Pathogenesis of Hypertension , 2001, Journal of cardiovascular pharmacology.

[16]  C. Bode,et al.  Induction of endothelin-1 expression by oxidative stress in vascular smooth muscle cells. , 2001, Cardiovascular pathology : the official journal of the Society for Cardiovascular Pathology.

[17]  D. Harrison,et al.  Oxidative stress and vascular damage in hypertension , 2001, Coronary artery disease.

[18]  S. Flavahan,et al.  Redox Regulation of Vascular Smooth Muscle Cell Differentiation , 2001, Circulation research.

[19]  T. Meinertz,et al.  Oxidative Stress Increases Endothelin‐1 Synthesis in Human Coronary Artery Smooth Muscle Cells , 2001, Journal of cardiovascular pharmacology.

[20]  M. Cobb,et al.  Mitogen-activated protein (MAP) kinase pathways: regulation and physiological functions. , 2001, Endocrine reviews.

[21]  D. Harrison,et al.  Electron spin resonance characterization of the NAD(P)H oxidase in vascular smooth muscle cells. , 2001, Free radical biology & medicine.

[22]  E. Schiffrin,et al.  Differential activation of extracellular signal-regulated protein kinase 1/2 and p38 mitogen activated-protein kinase by AT1 receptors in vascular smooth muscle cells from Wistar–Kyoto rats and spontaneously hypertensive rats , 2001, Journal of hypertension.

[23]  S. Eguchi,et al.  N-acetylcysteine inhibits angiotensin ii-mediated activation of extracellular signal-regulated kinase and epidermal growth factor receptor. , 2001, Biochemical and biophysical research communications.

[24]  T. Kubo,et al.  Mitogen-activated protein kinase activity regulation role of angiotensin and endothelin systems in vascular smooth muscle cells. , 2001, European journal of pharmacology.

[25]  E. Schiffrin,et al.  Signal transduction mechanisms mediating the physiological and pathophysiological actions of angiotensin II in vascular smooth muscle cells. , 2000, Pharmacological reviews.

[26]  D. Sorescu,et al.  Modulation of Protein Kinase Activity and Gene Expression by Reactive Oxygen Species and Their Role in Vascular Physiology and Pathophysiology , 2000, Arteriosclerosis, thrombosis, and vascular biology.

[27]  M. Wolin.  Interactions of oxidants with vascular signaling systems. , 2000, Arteriosclerosis, thrombosis, and vascular biology.

[28]  A. Dominiczak,et al.  Investigation into the sources of superoxide in human blood vessels: angiotensin II increases superoxide production in human internal mammary arteries. , 2000, Circulation.

[29]  J. Fei,et al.  Endothelin-1 and smooth muscle cells: induction of jun amino-terminal kinase through an oxygen radical-sensitive mechanism. , 2000, Arteriosclerosis, thrombosis, and vascular biology.

[30]  C. Elsing,et al.  Differential activation of mitogen-activated protein kinases in smooth muscle cells by angiotensin II: involvement of p22phox and reactive oxygen species. , 2000, Arteriosclerosis, thrombosis, and vascular biology.

[31]  W. Goettsch,et al.  Endothelin-1 induces NAD(P)H oxidase in human endothelial cells. , 2000, Biochemical and biophysical research communications.

[32]  M. White,et al.  Contribution of the ERK5/MEK5 Pathway to Ras/Raf Signaling and Growth Control* , 1999, The Journal of Biological Chemistry.

[33]  E. Schiffrin,et al.  Role of extracellular signal-regulated kinases in angiotensin II-stimulated contraction of smooth muscle cells from human resistance arteries. , 1999, Circulation.

[34]  D. Harrison,et al.  Validation of lucigenin as a chemiluminescent probe to monitor vascular superoxide as well as basal vascular nitric oxide production. , 1999, Biochemical and biophysical research communications.

[35]  W R Taylor,et al.  Role of NADH/NADPH oxidase-derived H2O2 in angiotensin II-induced vascular hypertrophy. , 1998, Hypertension.

[36]  T. Lüscher,et al.  Angiotensin II increases tissue endothelin and induces vascular hypertrophy: reversal by ET(A)-receptor antagonist. , 1997, Circulation.

[37]  B. Rovin,et al.  Interleukin-1β Induction of Mitogen-activated Protein Kinases in Human Mesangial Cells , 1997, The Journal of Biological Chemistry.

[38]  J. Abe,et al.  Big Mitogen-activated Protein Kinase 1 (BMK1) Is a Redox-sensitive Kinase* , 1996, The Journal of Biological Chemistry.

[39]  Qingbo Xu,et al.  Activation of Mitogen-activated Protein Kinase by HO , 1996, The Journal of Biological Chemistry.

[40]  M. Gorospe,et al.  Acute hypertension activates mitogen-activated protein kinases in arterial wall. , 1996, The Journal of clinical investigation.

[41]  B. Berk,et al.  Differential activation of mitogen-activated protein kinases by H2O2 and O2- in vascular smooth muscle cells. , 1995, Circulation research.

[42]  Jaung-Geng Lin,et al.  Angiotensin II induces endothelin-1 gene expression via extracellular signal-regulated kinase pathway in rat aortic smooth muscle cells. , 2004, Cardiovascular research.

[43]  M. Torres.  Mitogen-activated protein kinase pathways in redox signaling. , 2003, Frontiers in bioscience : a journal and virtual library.

[44]  W. Dröge.  Free radicals in the physiological control of cell function. , 2002, Physiological reviews.

[45]  K. Griendling,et al.  Functional evaluation of nonphagocytic NAD(P)H oxidases. , 2002, Methods in enzymology.

[46]  A. Segal,et al.  NADPH oxidase. , 1996, The international journal of biochemistry & cell biology.